These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20008180)

  • 1. Alpha thalassemia major--new mutations, intrauterine management, and outcomes.
    Vichinsky EP
    Hematology Am Soc Hematol Educ Program; 2009; ():35-41. PubMed ID: 20008180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
    Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
    Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of alpha(0)-thalassemia (--(SEA)/--(SEA)) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?
    Chmait RH; Baskin JL; Carson S; Randolph LM; Hamilton A
    Hematology; 2015 May; 20(4):217-22. PubMed ID: 25116001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Hb Bart's Hydrops Fetalis Caused by - -
    He S; Li J; Huang P; Zhang S; Lin L; Zuo Y; Tian X; Zheng C; Qiu X; Chen B
    Hemoglobin; 2018 Jan; 42(1):61-64. PubMed ID: 29493331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.
    Wang W; Yap CH; Loh SF; Tan AS; Lim MN; Prasath EB; Chan ML; Tan WC; Jiang B; Yeo GH; Mathew J; Ho A; Ho SS; Wong PC; Choolani MA; Chong SS
    Reprod Biomed Online; 2010 Nov; 21(5):642-8. PubMed ID: 20864413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening.
    Li D; Liao C; Li J; Xie X; Huang Y; Zhong H
    Haematologica; 2006 May; 91(5):649-51. PubMed ID: 16627247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants.
    Siriratmanawong N; Pinmuang-Ngam C; Fucharoen G; Fucharoen S
    Fetal Diagn Ther; 2007; 22(4):264-8. PubMed ID: 17369692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy.
    Vichinsky E
    Ann N Y Acad Sci; 2010 Aug; 1202():180-7. PubMed ID: 20712791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze.
    Liao C; Li J; Xie XM; Zhou JY; Li DZ
    Ann Hematol; 2009 Nov; 88(11):1145-7. PubMed ID: 19259674
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis.
    Chui DH
    Ann N Y Acad Sci; 2005; 1054():25-32. PubMed ID: 16339648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].
    Zhu BS; He J; Zhang J; Zeng XH; Su J; Xu XH; Li SY; Chen H; Zhang YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):85-9. PubMed ID: 22455737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.
    Beris P; Darbellay R; Extermann P
    Semin Hematol; 1995 Oct; 32(4):244-61. PubMed ID: 8560282
    [No Abstract]   [Full Text] [Related]  

  • 13. Early onset of fetal hydrops associated with the α-thalassemia - -(THAI) deletion.
    Yang Y; Li DZ
    Hemoglobin; 2014; 38(6):431-4. PubMed ID: 25370866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of α-thalassemia.
    Vichinsky EP
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a011742. PubMed ID: 23543077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Hb Bart's (γ4) Disease Associated with the - -(THAI) α(0)-Thalassemia Deletion in Mainland China.
    Li DZ; Li Y; Li J; Li SC; Li R
    Hemoglobin; 2015; 39(6):412-4. PubMed ID: 26212676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation.
    Yi JS; Moertel CL; Baker KS
    J Pediatr; 2009 May; 154(5):766-8. PubMed ID: 19364562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of hemoglobin Bart's disease caused by co-inheritance of two different alpha 0-thalassemia defects in China.
    Li DZ; Li J; Liao C
    Prenat Diagn; 2009 Jun; 29(6):632-3. PubMed ID: 19294754
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- -
    Yang X; Yan JM; Li J; Xie XM; Zhou JY; Li Y; Li DZ
    Hemoglobin; 2016 Sep; 40(5):353-355. PubMed ID: 27686733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of real-time PCR cycle threshold of alpha-thalassemia-1 Southeast Asian type deletion using fetal cell-free DNA in maternal plasma for noninvasive prenatal diagnosis of Bart's hydrops fetalis.
    Pornprasert S; Sukunthamala K; Kunyanone N; Sittiprasert S; Thungkham K; Junorse S; Pongsawatkul K; Pattanaporn W; Jitwong C; Sanguansermsri T
    J Med Assoc Thai; 2010 Nov; 93(11):1243-8. PubMed ID: 21114201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of non-haematological cause of fetal hydrops in at-risk pregnancies for homozygous α0-thalassemia.
    Wei JX; Liao C; Li DZ
    J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1320-2. PubMed ID: 20942600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.